- NCT00000299
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
Phase 2Completed - NCT00000297
Effects of Labetalol on Nicotine Administration in Humans - 14
Phase 2Completed - NCT00000245
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Phase 2Completed - NCT00000300
Feasibility Study of Take-Home LAAM Medication - 3
Phase 4Completed - NCT00000221
Alternate-Day Buprenorphine Administration. Phase I - 3
Phase 1Completed - NCT00000201
Pharmacological Modulation of Cocaine Effects - 1
Phase 2Completed - NCT00000200
Cocaine Effects in Humans: Physiology and Behavior - 1
Phase 2Completed - NCT00000199
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
Phase 1Withdrawn - NCT00000269
Pergolide Treatment for Substance Abusers - 4
Phase 2Completed - NCT00000268
Cocaine Abuse and Attention Deficit Disorder - 3
Not ApplicableCompleted - NCT00000198
Piracetam for Treatment of Cocaine Addiction - 3
Phase 1Completed - NCT00000270
Brain Imaging: Cocaine Effects & Medication Development - 5
Phase 4Withdrawn - NCT00000267
Risperidone Treatment in Dually-Diagnosed Individuals - 2
Phase 2Completed - NCT00000266
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
Phase 2Completed - NCT00000265
Subjective Effects of Nitrous Oxide in Dental Patients - 17
Completed - NCT00000202
Buprenorphine Maintenance for Opioid Addicts - 1
Phase 2Completed - NCT00000264
Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
Not ApplicableCompleted - NCT00000197
Propranolol for Treatment of Cocaine Addiction - 2
Phase 2Completed - NCT00000196
Neurobiology of Opioid Dependence: 5 - 5
Phase 2Withdrawn - NCT00000195
Neurobiology of Opioid Dependence: 4 - 4
Phase 2Withdrawn - NCT00000273
A Laboratory Model for Heroin Abuse Medications - 8
Phase 2Completed - NCT00000263
Effects of Combined Alcohol and Nitrous Oxide Intake - 15
Not ApplicableCompleted - NCT00000194
Neurobiology of Opioid Dependence: 3 - 3
Phase 2Withdrawn - NCT00000274
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
Phase 2Completed - NCT00000203
Buprenorphine Maintenance for Opioid Addicts - 2
Phase 2Completed - NCT00000275
Cocaine Abuse and ADHD - 10
Phase 2Completed - NCT00000276
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
Phase 1Terminated - NCT00000277
Mazindol for Cocaine Abuse - 2
Phase 2Completed - NCT00000193
Neurobiology of Opioid Dependence: 2 - 2
Phase 2Withdrawn - NCT00000278
Disulfiram for Cocaine-Alcohol Abuse - 3
Phase 2Completed - NCT00000279
Novel Medications for Opiate Detoxification - 4
Phase 2Completed - NCT00000280
Glutaminergic Agents for Cocaine Abuse - 5
Phase 1Completed - NCT00000281
Pharmacotherapy for Schizophrenic Drug Users - 6
Phase 2Completed - NCT00000258
Role of Instructions in Nitrous Oxide Effects and Choice - 10
Not ApplicableCompleted - NCT00000257
Effects of Alcohol History on Effects of Nitrous Oxide - 9
Not ApplicableCompleted - NCT00000219
Buprenorphine Dose Alteration Study - 1
Phase 1Completed - NCT00000356
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Phase 2Completed - NCT00000357
Buprenorphine Maintenance for Opiate Dependence - 6
Phase 2Completed - NCT00000241
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Phase 2Completed - NCT00000216
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Phase 3Completed - NCT00000229
Buprenorphine Detox With Two Types of Treatment. BBD II - 11
Phase 2Completed - NCT00000230
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Phase 2Completed - NCT00000240
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
Phase 2Completed - NCT00000358
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Phase 1Completed - NCT00000355
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
Phase 1Completed - NCT00000220
Gradual Vs. Rapid Buprenorphine Detoxification - 2
Phase 1Completed - NCT00000354
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Phase 1Completed - NCT00000353
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Phase 2Completed - NCT00000228
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
Phase 2Completed - NCT00000214
IV Cocaine Abuse: A Laboratory Model - 3
Phase 2Completed - NCT00000352
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Phase 2Completed - NCT00000227
Alternate-Day Buprenorphine Administration. Phase VIII - 9
Phase 2Completed - NCT00000231
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Phase 2Completed - NCT00000351
Cognitive Correlates of Substance Abuse, Part 2 - 16
Unknown - NCT00000217
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
Phase 2Completed - NCT00000350
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
Phase 1Unknown - NCT00000349
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
Phase 1Unknown - NCT00000204
Buprenorphine Maintenance for Opioid Addicts - 3
Phase 2Completed - NCT00000348
Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
Phase 1Unknown - NCT00000347
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
Phase 2Completed - NCT00000226
Alternate-Day Buprenorphine Administration. Phase VII - 8
Phase 2Completed - NCT00000242
Carbamazepine Treatment of Cocaine Dependence - 1
Phase 2Completed - NCT00000213
IV Cocaine Abuse: A Laboratory Model - 2
Phase 2Completed - NCT00000239
Buprenorphine Pharmacology Related to Addiction Treatment - 21
Phase 2Completed - NCT00000345
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Phase 1Completed - NCT00000215
IV Cocaine Abuse: A Laboratory Model - 4
Phase 2Completed - NCT00000344
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Phase 2Completed - NCT00000342
Risperidone for the Treatment of Cocaine Dependence - 7
Phase 2Completed - NCT00000232
Alternate Day Buprenorphine Administration, Phase IX - 14
Phase 2Completed - NCT00000341
Evaluation of Liquid vs. Tablet Buprenorphine - 6
Phase 2Completed - NCT00000340
Pemoline in the Treatment of Stimulant Dependence - 5
Phase 2Withdrawn - NCT00000339
Infusion Laboratory: Protocol 3 (Risperidone) - 4
Phase 1Unknown - NCT00000338
Infusion Laboratory: Protocol 2 (Lisuride) - 3
Phase 1Unknown - NCT00000225
Alternate-Day Buprenorphine Administration. Phase VI - 7
Phase 2Completed - NCT00000259
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
Not ApplicableCompleted - NCT00000254
Isoflurane at Subanesthetic Concentrations - 6
Phase 2Completed - NCT00000317
Early Phase II Trials for Cocaine Medication Development - 1
Phase 2Completed - NCT00000331
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Phase 2Withdrawn - NCT00000262
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
Not ApplicableCompleted - NCT00000308
Dextroamphetamine-Cocaine Behavioral Intervention - 5
Phase 2Completed - NCT00000261
Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
Phase 2Completed - NCT00000324
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
Phase 2Completed - NCT00000260
Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
Not ApplicableCompleted - NCT00000346
Cognitive Correlates of Substance Abuse - 11
Phase 4Unknown - NCT00000271
New Approaches to Cocaine Abuse Medications (A) - 6
Phase 2Completed - NCT00004639
Cleft Palate Surgery and Speech Development
Phase 2Completed - NCT00004640
"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Phase 3Completed